These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12435111)
1. Synergism between urinary prothrombin fragment 1 and urine: a comparison of inhibitory activities in stone-prone and stone-free population groups. Webber D; Rodgers AL; Sturrock ED Clin Chem Lab Med; 2002 Sep; 40(9):930-6. PubMed ID: 12435111 [TBL] [Abstract][Full Text] [Related]
2. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine. Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110 [TBL] [Abstract][Full Text] [Related]
3. A study of crystal matrix extract and urinary prothrombin fragment 1 from a stone-prone and stone-free population. Durrbaum D; Rodgers AL; Sturrock ED Urol Res; 2001 Apr; 29(2):83-8. PubMed ID: 11396733 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity. Grover PK; Ryall RL Eur J Biochem; 1999 Jul; 263(1):50-6. PubMed ID: 10429186 [TBL] [Abstract][Full Text] [Related]
5. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Ryall RL; Grover PK; Stapleton AM; Barrell DK; Tang Y; Moritz RL; Simpson RJ Clin Sci (Lond); 1995 Nov; 89(5):533-41. PubMed ID: 8549069 [TBL] [Abstract][Full Text] [Related]
6. Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation. Webber D; Radcliffe CM; Royle L; Tobiasen G; Merry AH; Rodgers AL; Sturrock ED; Wormald MR; Harvey DJ; Dwek RA; Rudd PM FEBS J; 2006 Jul; 273(13):3024-37. PubMed ID: 16817853 [TBL] [Abstract][Full Text] [Related]
7. The hole truth: intracrystalline proteins and calcium oxalate kidney stones. Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707 [TBL] [Abstract][Full Text] [Related]
8. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity. Grover PK; Ryall RL Clin Sci (Lond); 2002 Apr; 102(4):425-34. PubMed ID: 11914105 [TBL] [Abstract][Full Text] [Related]
9. Proteolysis and partial dissolution of calcium oxalate: a comparative, morphological study of urinary crystals from black and white subjects. Webber D; Chauvet MC; Ryall RL Urol Res; 2005 Aug; 33(4):273-84. PubMed ID: 15877223 [TBL] [Abstract][Full Text] [Related]
10. Calcium phosphate crystal-associated proteins: alpha-2-HS-glycoprotein, prothrombin fragment 1 and osteopontin. Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M Int J Urol; 2001 Aug; 8(8):S58-62. PubMed ID: 11555022 [TBL] [Abstract][Full Text] [Related]
11. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals. Ryall RL; Chauvet MC; Grover PK BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927 [TBL] [Abstract][Full Text] [Related]
12. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus. Liu J; Chen J; Wang T; Wang S; Ye Z J Urol; 2005 Jan; 173(1):113-6. PubMed ID: 15592049 [TBL] [Abstract][Full Text] [Related]
13. The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects. Lewandowski S; Rodgers A; Schloss I BJU Int; 2001 Mar; 87(4):307-11. PubMed ID: 11251520 [TBL] [Abstract][Full Text] [Related]
14. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Atmani F; Glenton PA; Khan SR Urol Res; 1998; 26(3):201-7. PubMed ID: 9694603 [TBL] [Abstract][Full Text] [Related]
15. Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix. Stapleton AM; Dawson CJ; Grover PK; Hohmann A; Comacchio R; Boswarva V; Tang Y; Ryall RL Kidney Int; 1996 Mar; 49(3):880-8. PubMed ID: 8648933 [TBL] [Abstract][Full Text] [Related]
16. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation. Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440 [TBL] [Abstract][Full Text] [Related]
17. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Bergsland KJ; Kelly JK; Coe BJ; Coe FL Am J Physiol Renal Physiol; 2006 Sep; 291(3):F530-6. PubMed ID: 16622176 [TBL] [Abstract][Full Text] [Related]
18. Effect of urine fractionation on attachment of calcium oxalate crystals to renal epithelial cells: implications for studying renal calculogenesis. Grover PK; Thurgood LA; Ryall RL Am J Physiol Renal Physiol; 2007 May; 292(5):F1396-403. PubMed ID: 17267387 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth and aggregation of calcium oxalate crystals in vitro--a comparison of four human proteins. Grover PK; Moritz RL; Simpson RJ; Ryall RL Eur J Biochem; 1998 May; 253(3):637-44. PubMed ID: 9654060 [TBL] [Abstract][Full Text] [Related]